Rossmore Private Capital’s GSK GSK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$220K Hold
4,518
– – 0.02% 295
2026
Q2
$239K Hold
4,518
– – 0.02% 282
2026
Q1
$252K Hold
4,518
– – 0.02% 267
2025
Q4
$223K Buy
+4,518
New +$211K 0.02% 272
2022
Q3
– Sell
-3,785
Closed -$206K – 224
2022
Q2
$206K Buy
+3,785
New +$209K 0.04% 218
2018
Q1
– Sell
-176
Closed -$7.8K – 233
2017
Q4
$7.8K Buy
+176
New +$8.13K 0.01% 323

Other funds holding GSK

Rossmore Private Capital's GSK Position: Q3 2026 in Review

Rossmore Private Capital held its GSK (GSK) position steady in Q3 2026 at 4,518 shares worth $220K. The position accounts for 0.02% of the portfolio, ranked #295.

Rossmore Private Capital first reported a position in GSK in Q4 2017 and has held it in 6 quarters since. The position peaked at $252K in Q1 2026. 986 funds tracked by Wall St. Rank hold GSK as of Q3 2026.

  • Rossmore Private Capital held 4,518 shares of GSK worth $220K as of Q3 2026.
  • Rossmore Private Capital left its GSK share count unchanged in Q3 2026.
  • GSK made up 0.02% of Rossmore Private Capital's portfolio in Q3 2026, its #295 holding.
  • Rossmore Private Capital first reported a position in GSK in Q4 2017 and has held it in 6 quarters since.
  • Rossmore Private Capital's GSK position peaked at $252K in Q1 2026.
  • 986 funds tracked by Wall St. Rank held GSK as of Q3 2026.

Based on Rossmore Private Capital's 13F filing for Q3 2026, filed 27 Oct 2026.